310 filings
Page 5 of 16
8-K
pz3zvuvnm96kag51z
8 Dec 21
Oncocyte and Burning Rock Complete Technology Transfer Part Two and Prepare for Scaled Distribution
8:05am
8-K
my9oui bkamqa
9 Nov 21
Oncocyte Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:37pm
8-K
dccvhy ihtx
4 Nov 21
Oncocyte Announces the Clinical Launch of DetermaIO Immunotherapy Response Prediction Test
8:05am
8-K
zd4uyjsyzxd474ggr
27 Oct 21
U.S. patent builds upon prior EU patent protection enabling launch of Therasure Transplant Monitor LDT and FDA kits in both the U.S. and Europe
8:05am
8-K
4ycnlc4qm97q1niejic
7 Oct 21
Oncocyte Appoints Gisela A. Paulsen as Chief Operating Officer
8:05am
8-K
wn4crfv6z
20 Sep 21
Oncocyte Announces Oral Presentation of New Data on Its DetermaIO™ Immunotherapy
11:40am
8-K
rwzim1n hqieh011
10 Aug 21
Oncocyte Reports Second Quarter 2021 Financial Results and Provides Corporate Update
5:12pm
EFFECT
fo7l4rh
30 Jul 21
Notice of effectiveness
12:15am
424B3
cgfr don5ruk9o
29 Jul 21
Prospectus supplement
4:01pm
CORRESP
7xpcct 3lgq
26 Jul 21
Correspondence with SEC
12:00am
UPLOAD
kb4qnd 8fihons97ms
21 Jul 21
Letter from SEC
12:00am
8-K
dxv9syl
20 Jul 21
Changes in Registrant's Certifying Accountant
4:47pm
S-8
9lun f9yj
7 Jul 21
Registration of securities for employees
4:05pm
8-K
lu79135f5
28 Jun 21
Submission of Matters to a Vote of Security Holders
5:17pm
8-K
j62qv
24 Jun 21
Regulation FD Disclosure
8:00am
424B5
6p0i vq5n
14 Jun 21
Prospectus supplement for primary offering
12:00am
8-K
7sib5
14 Jun 21
Entry into a Material Definitive Agreement
12:00am